Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of creatine analogues and creatine kinase modulators for the prevention and treatment of glucose metabolic disorders

Use of creatine analogues and creatine kinase modulators for the prevention and treatment of glucose metabolic disorders

US Patent 6075031 · Granted Jun 13, 2000

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modulating the aryl hydrocarbon receptor system to treat major depressive disord2021
Lipidomics approaches for central nervous system disorders2014
Biomarkers for depression and methods using the same2013
Lipidomic approaches to determining drug response phenotypes in cardiovascular d2012
Methods for drug discovery, disease treatment, and diagnosis using metabolomics2011
Methods for drug discovery, disease treatment, and diagnosis using metabolomics2011
Methods for drug discovery, disease treatment, and diagnosis using metabolomics2010
Methods for drug discovery disease treatment, and diagnosis using metabolomics2010
Methods for drug discovery, disease treatment, and diagnosis using metabolomics2009
Induction of apoptosis by cellular stress2009
Methods for drug discovery, disease treatment, and diagnosis using metabolomics2009
Methods for drug discovery, disease treatment, and diagnosis using metabolomics2009